Transforming MIBC Treatment: Insights from the NIAGARA Trial Posted on February 16, 2025 The landscape of treating muscle-invasive bladder cancer (MIBC) has potentially shifted with the latest insights from the phase III NIAGARA trial. Here’s a concise overview of what you need to know: Understanding MIBC: NIAGARA Trial Highlights: Clinical Implications: Conclusion & Future Directions: … Continue reading Durvalumab / Imfinzi Defies Expectations in MIBC, Offering Survival Gains Beyond Complete Response in NIAGARA Trial – ASCO GU 2025